CD163 and congenital rubella syndrome: Elevated serum soluble CD147 (sCD147), an inhibitor of extracellular matrix metalloproteinase, and CD163 (sCD163), a cysteine-rich scavenger receptor, have been demonstrated in patients with CRS [19,141,142,143,144,145,146,147,148,149,150].